The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Microbiome Therapeutic Drugs Market Research Report 2024
Synopsis
Human microbiome therapeutic drugs are drugs made by using the relationship between the gene content of the microbiota and metabolic activities.
The global Human Microbiome Therapeutic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Microbiome Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Therapeutic Drugs.
Report Scope
The Human Microbiome Therapeutic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Microbiome Therapeutic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Microbiome Therapeutic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson and Johnson
Takeda
ENTEROME Bioscience
Segment by Type
FMT
Microbiome Drugs
Others
Segment by Application
Stomach
Oral
Respiratory Tract
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome Therapeutic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Human microbiome therapeutic drugs are drugs made by using the relationship between the gene content of the microbiota and metabolic activities.
The global Human Microbiome Therapeutic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Human Microbiome Therapeutic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Microbiome Therapeutic Drugs.
Report Scope
The Human Microbiome Therapeutic Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Microbiome Therapeutic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Microbiome Therapeutic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Bristol-Myers Squibb
Johnson and Johnson
Takeda
ENTEROME Bioscience
Segment by Type
FMT
Microbiome Drugs
Others
Segment by Application
Stomach
Oral
Respiratory Tract
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Human Microbiome Therapeutic Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Microbiome Therapeutic Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 FMT
1.2.3 Microbiome Drugs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Human Microbiome Therapeutic Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Stomach
1.3.3 Oral
1.3.4 Respiratory Tract
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Human Microbiome Therapeutic Drugs Market Perspective (2019-2030)
2.2 Human Microbiome Therapeutic Drugs Growth Trends by Region
2.2.1 Global Human Microbiome Therapeutic Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Human Microbiome Therapeutic Drugs Historic Market Size by Region (2019-2024)
2.2.3 Human Microbiome Therapeutic Drugs Forecasted Market Size by Region (2025-2030)
2.3 Human Microbiome Therapeutic Drugs Market Dynamics
2.3.1 Human Microbiome Therapeutic Drugs Industry Trends
2.3.2 Human Microbiome Therapeutic Drugs Market Drivers
2.3.3 Human Microbiome Therapeutic Drugs Market Challenges
2.3.4 Human Microbiome Therapeutic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Microbiome Therapeutic Drugs Players by Revenue
3.1.1 Global Top Human Microbiome Therapeutic Drugs Players by Revenue (2019-2024)
3.1.2 Global Human Microbiome Therapeutic Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Human Microbiome Therapeutic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Human Microbiome Therapeutic Drugs Revenue
3.4 Global Human Microbiome Therapeutic Drugs Market Concentration Ratio
3.4.1 Global Human Microbiome Therapeutic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Therapeutic Drugs Revenue in 2023
3.5 Human Microbiome Therapeutic Drugs Key Players Head office and Area Served
3.6 Key Players Human Microbiome Therapeutic Drugs Product Solution and Service
3.7 Date of Enter into Human Microbiome Therapeutic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Microbiome Therapeutic Drugs Breakdown Data by Type
4.1 Global Human Microbiome Therapeutic Drugs Historic Market Size by Type (2019-2024)
4.2 Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Type (2025-2030)
5 Human Microbiome Therapeutic Drugs Breakdown Data by Application
5.1 Global Human Microbiome Therapeutic Drugs Historic Market Size by Application (2019-2024)
5.2 Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Human Microbiome Therapeutic Drugs Market Size (2019-2030)
6.2 North America Human Microbiome Therapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Human Microbiome Therapeutic Drugs Market Size by Country (2019-2024)
6.4 North America Human Microbiome Therapeutic Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Human Microbiome Therapeutic Drugs Market Size (2019-2030)
7.2 Europe Human Microbiome Therapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Human Microbiome Therapeutic Drugs Market Size by Country (2019-2024)
7.4 Europe Human Microbiome Therapeutic Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size (2019-2030)
8.2 Asia-Pacific Human Microbiome Therapeutic Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Human Microbiome Therapeutic Drugs Market Size (2019-2030)
9.2 Latin America Human Microbiome Therapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Human Microbiome Therapeutic Drugs Market Size by Country (2019-2024)
9.4 Latin America Human Microbiome Therapeutic Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size (2019-2030)
10.2 Middle East & Africa Human Microbiome Therapeutic Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Rebiotix
11.1.1 Rebiotix Company Detail
11.1.2 Rebiotix Business Overview
11.1.3 Rebiotix Human Microbiome Therapeutic Drugs Introduction
11.1.4 Rebiotix Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024)
11.1.5 Rebiotix Recent Development
11.2 Seres Therapeutics
11.2.1 Seres Therapeutics Company Detail
11.2.2 Seres Therapeutics Business Overview
11.2.3 Seres Therapeutics Human Microbiome Therapeutic Drugs Introduction
11.2.4 Seres Therapeutics Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024)
11.2.5 Seres Therapeutics Recent Development
11.3 Vedanta Biosciences
11.3.1 Vedanta Biosciences Company Detail
11.3.2 Vedanta Biosciences Business Overview
11.3.3 Vedanta Biosciences Human Microbiome Therapeutic Drugs Introduction
11.3.4 Vedanta Biosciences Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024)
11.3.5 Vedanta Biosciences Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Introduction
11.4.4 Bristol-Myers Squibb Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Johnson and Johnson
11.5.1 Johnson and Johnson Company Detail
11.5.2 Johnson and Johnson Business Overview
11.5.3 Johnson and Johnson Human Microbiome Therapeutic Drugs Introduction
11.5.4 Johnson and Johnson Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024)
11.5.5 Johnson and Johnson Recent Development
11.6 Takeda
11.6.1 Takeda Company Detail
11.6.2 Takeda Business Overview
11.6.3 Takeda Human Microbiome Therapeutic Drugs Introduction
11.6.4 Takeda Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024)
11.6.5 Takeda Recent Development
11.7 ENTEROME Bioscience
11.7.1 ENTEROME Bioscience Company Detail
11.7.2 ENTEROME Bioscience Business Overview
11.7.3 ENTEROME Bioscience Human Microbiome Therapeutic Drugs Introduction
11.7.4 ENTEROME Bioscience Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024)
11.7.5 ENTEROME Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Human Microbiome Therapeutic Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of FMT
Table 3. Key Players of Microbiome Drugs
Table 4. Key Players of Others
Table 5. Global Human Microbiome Therapeutic Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Human Microbiome Therapeutic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Human Microbiome Therapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Human Microbiome Therapeutic Drugs Market Share by Region (2019-2024)
Table 9. Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Human Microbiome Therapeutic Drugs Market Share by Region (2025-2030)
Table 11. Human Microbiome Therapeutic Drugs Market Trends
Table 12. Human Microbiome Therapeutic Drugs Market Drivers
Table 13. Human Microbiome Therapeutic Drugs Market Challenges
Table 14. Human Microbiome Therapeutic Drugs Market Restraints
Table 15. Global Human Microbiome Therapeutic Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Human Microbiome Therapeutic Drugs Market Share by Players (2019-2024)
Table 17. Global Top Human Microbiome Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutic Drugs as of 2023)
Table 18. Ranking of Global Top Human Microbiome Therapeutic Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Human Microbiome Therapeutic Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Human Microbiome Therapeutic Drugs Product Solution and Service
Table 22. Date of Enter into Human Microbiome Therapeutic Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Microbiome Therapeutic Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Human Microbiome Therapeutic Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Human Microbiome Therapeutic Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Human Microbiome Therapeutic Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Human Microbiome Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Human Microbiome Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Human Microbiome Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Human Microbiome Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Human Microbiome Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Human Microbiome Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Human Microbiome Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Human Microbiome Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Human Microbiome Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Rebiotix Company Detail
Table 48. Rebiotix Business Overview
Table 49. Rebiotix Human Microbiome Therapeutic Drugs Product
Table 50. Rebiotix Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 51. Rebiotix Recent Development
Table 52. Seres Therapeutics Company Detail
Table 53. Seres Therapeutics Business Overview
Table 54. Seres Therapeutics Human Microbiome Therapeutic Drugs Product
Table 55. Seres Therapeutics Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 56. Seres Therapeutics Recent Development
Table 57. Vedanta Biosciences Company Detail
Table 58. Vedanta Biosciences Business Overview
Table 59. Vedanta Biosciences Human Microbiome Therapeutic Drugs Product
Table 60. Vedanta Biosciences Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 61. Vedanta Biosciences Recent Development
Table 62. Bristol-Myers Squibb Company Detail
Table 63. Bristol-Myers Squibb Business Overview
Table 64. Bristol-Myers Squibb Human Microbiome Therapeutic Drugs Product
Table 65. Bristol-Myers Squibb Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 66. Bristol-Myers Squibb Recent Development
Table 67. Johnson and Johnson Company Detail
Table 68. Johnson and Johnson Business Overview
Table 69. Johnson and Johnson Human Microbiome Therapeutic Drugs Product
Table 70. Johnson and Johnson Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 71. Johnson and Johnson Recent Development
Table 72. Takeda Company Detail
Table 73. Takeda Business Overview
Table 74. Takeda Human Microbiome Therapeutic Drugs Product
Table 75. Takeda Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 76. Takeda Recent Development
Table 77. ENTEROME Bioscience Company Detail
Table 78. ENTEROME Bioscience Business Overview
Table 79. ENTEROME Bioscience Human Microbiome Therapeutic Drugs Product
Table 80. ENTEROME Bioscience Revenue in Human Microbiome Therapeutic Drugs Business (2019-2024) & (US$ Million)
Table 81. ENTEROME Bioscience Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Microbiome Therapeutic Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Human Microbiome Therapeutic Drugs Market Share by Type: 2023 VS 2030
Figure 3. FMT Features
Figure 4. Microbiome Drugs Features
Figure 5. Others Features
Figure 6. Global Human Microbiome Therapeutic Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Human Microbiome Therapeutic Drugs Market Share by Application: 2023 VS 2030
Figure 8. Stomach Case Studies
Figure 9. Oral Case Studies
Figure 10. Respiratory Tract Case Studies
Figure 11. Others Case Studies
Figure 12. Human Microbiome Therapeutic Drugs Report Years Considered
Figure 13. Global Human Microbiome Therapeutic Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Human Microbiome Therapeutic Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Human Microbiome Therapeutic Drugs Market Share by Region: 2023 VS 2030
Figure 16. Global Human Microbiome Therapeutic Drugs Market Share by Players in 2023
Figure 17. Global Top Human Microbiome Therapeutic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Microbiome Therapeutic Drugs as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Human Microbiome Therapeutic Drugs Revenue in 2023
Figure 19. North America Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Human Microbiome Therapeutic Drugs Market Share by Country (2019-2030)
Figure 21. United States Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Human Microbiome Therapeutic Drugs Market Share by Country (2019-2030)
Figure 25. Germany Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Human Microbiome Therapeutic Drugs Market Share by Region (2019-2030)
Figure 33. China Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Human Microbiome Therapeutic Drugs Market Share by Country (2019-2030)
Figure 41. Mexico Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Human Microbiome Therapeutic Drugs Market Share by Country (2019-2030)
Figure 45. Turkey Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Human Microbiome Therapeutic Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Rebiotix Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2019-2024)
Figure 48. Seres Therapeutics Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2019-2024)
Figure 49. Vedanta Biosciences Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2019-2024)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2019-2024)
Figure 51. Johnson and Johnson Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2019-2024)
Figure 52. Takeda Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2019-2024)
Figure 53. ENTEROME Bioscience Revenue Growth Rate in Human Microbiome Therapeutic Drugs Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
